The urothelium lines the bladder and protects it from bacteria and toxic or carcinogenic substances in the urine by maintaining an impermeable barrier. Although this functions remarkably well, it fails in bladder cancer, interstitial cystitis, and possibly other diseases as well. Understanding how the urothelium grows and differentiates and carries out its function may provide important clues to the diagnosis and treatment of bladder diseases. Although urothelium can be cultured, most models fail to adequately model the interactions between the urothelium and the underlying stroma. Together the two form a complex and interacting system. This proposal describes studies to meet the requirements of a PAR to develop cell-selective tools, specifically item (8) identification of cell specific markers to aid studies of epithelial-stromal interactions in normal and malignant tissues and secondarily item (5) discovery of biomarkers that indicate health or mass of individual cell types and item (1) discovery of genes selective to individual cell types. Novel methods for growth of urothelium as an artificial tissue in 3-dimensions and for bladder cancers as artificial tumors on both normal and cancer-modified matrix provides a basis for discovering the genes and proteins involved in defining normal and malignant urothelium. In a first discovery phase, microarrays and a novel proteomics approach with 2-D chromatography will be combined with innovative bioinformatics approaches to identify candidate genes and proteins. A public database of gene expression and protein levels will be constructed. Candidate genes/proteins will be validated sequentially, first by data mining and informatics to identify plausible mechanisms and to compare with other expression data, then biochemically by immunohistochemistry or quantitative PCR. A limited number of the most interesting genes will be investigated in greater depth in a second phase of hypothesis testing. Expression will be forced in cell lines not expressing a gene or knocked down in those that do. The """"""""deliverables"""""""" will be sets of genes and proteins subjected to several levels of verification for their role in aiding studies of epithelial-stromal interactions in normal and malignant tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK069808-03
Application #
7220561
Study Section
Special Emphasis Panel (ZRG1-RUS-D (50))
Program Officer
Rasooly, Rebekah S
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
3
Fiscal Year
2007
Total Cost
$298,172
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Urology
Type
Schools of Medicine
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Hurst, Robert E; Bastian, Anja; Bailey-Downs, Lora et al. (2016) Targeting dormant micrometastases: rationale, evidence to date and clinical implications. Ther Adv Med Oncol 8:126-37
Hauser, Paul J; VanGordon, Samuel B; Seavey, Jonathan et al. (2015) Abnormalities in Expression of Structural, Barrier and Differentiation Related Proteins, and Chondroitin Sulfate in Feline and Human Interstitial Cystitis. J Urol 194:571-7
Hurst, Robert E; Hauser, Paul J; You, Youngjae et al. (2015) Identification of novel drugs to target dormant micrometastases. BMC Cancer 15:404
Marentette, John O; Hauser, Paul J; Hurst, Robert E et al. (2013) Tryptase activation of immortalized human urothelial cell mitogen-activated protein kinase. PLoS One 8:e69948
Hurst, Robert E; Hauser, Paul J; Kyker, Kimberly D et al. (2013) Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell ""dormancy"". PLoS One 8:e64181
Engles, Christopher D; Hauser, Paul J; Abdullah, Shivon N et al. (2012) Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage ""leaky bladder"" model of cystitis. Urology 79:483.e13-7
Zhang, Dianzhong; Hudson, Amber E; Delostrinos, Catherine F et al. (2011) Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream. Am J Physiol Renal Physiol 300:F475-87
Dozmorov, Mikhail; Stone 2nd, Randolph; Clifford, John L et al. (2011) System level changes in gene expression in maturing bladder mucosa. J Urol 185:1952-8
Dozmorov, Mikhail G; Guthridge, Joel M; Hurst, Robert E et al. (2010) A comprehensive and universal method for assessing the performance of differential gene expression analyses. PLoS One 5:
Dozmorov, Mikhail G; Azzarello, Joseph T; Wren, Jonathan D et al. (2010) Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression. BMC Cancer 10:672

Showing the most recent 10 out of 20 publications